|
[1]
|
Funke H, Assmann G. Strategies for the assessment of genetic coronary artery disease risk[J]. Cur Opin Lipidol, 1999, 10:285-291. doi: 10.1097/00041433-199906000-00011 |
|
[2]
|
Scarabin PY, Arveiler D, Amouyel P, et al. Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study[J]. Atherosclerosis, 2003, 166: 103-109. doi: 10.1016/S0021-9150(02)00309-X |
|
[3]
|
Behague I, Poirier 0, Nicaud V, et al. β fibrinogen gene polymorphisms are associated with plasma fbrinogen and coronary artery disease in patients with myocardial infarction [J]. Girculation, 1996, 93:440-449 doi: 10.1161/01.CIR.93.3.440 |
|
[4]
|
Carter AM, Mansfield MW, Stickland MH, et al. β fibrinogen gene 455 G/A polymorphism and fibrinogen levels: risk factors for coronary artery disease in subjects with NIDDM [J]. Diabetes Care, 1996, 9:1265-1268. https://care.diabetesjournals.org/content/19/11/1265 |
|
[5]
|
de Maat MPM, Kastelein JJP, Jukema JW, et al. 455G/A polymorphism of the b-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute phase reaction pattern of fibrinogen[J]. Arterioscler Thromb Vasc Biol, 1998, 18:265-271. doi: 10.1161/01.ATV.18.2.265 |
|
[6]
|
Zito F, Di Castelnuovo A, Amore C, et al. Bel I polymorphism in the fibrinogen b-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels: a case-control study in a sample of GISSI-2 patients[J]. Arterioscler Thromb Vasc Biol, 1997, 17: 3489-3494. doi: 10.1161/01.ATV.17.12.3489 |
|
[7]
|
Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, et al. A common mutation (G 455-A) in the b-fibrinogen promoter is an independent predictor of plasma fbrinogen, but not of ischemic heart disease: a study of9, 127 individuals based on the Copenhagen City Heart Study[J]. J Clin Invest, 1997, 99:3034-3039. doi: 10.1172/JCI119499 |
|
[8]
|
Wang XL, Wang J, MeCredie RM, et al. Polymorphisms of factor V, factor VⅡ, and fibrinogen genes: relevance to severity of coronary artery disease[J]. Arterioscler Thromb Vasc Biol, 1997, 17:246-251. doi: 10.1161/01.ATV.17.2.246 |
|
[9]
|
Boekholdt SM, Bijsterveld NR, Moons AH, et al. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review [J]. Circulation, 2001, 104:3063-3068. doi: 10.1161/hc5001.100793 |
|
[10]
|
Lane A, Green F, Scarabin PY, et al. Factor VⅡ Arg/Gln353 polymorphism determines factor VⅡ coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indication of MI risk in the ECTIM study[J]. Atherosclerosis, 1996, 119:119-127. doi: 10.1016/0021-9150(95)05638-6 |
|
[11]
|
Doggen CJM, Cats VM, Bertina RM, et al. A genetic propensity to high factor VⅡ is not associated with the risk of myocardial infarctin in men[J]. Thromb Haemost, 1998, 80:281-285. doi: 10.1055/s-0037-1615188 |
|
[12]
|
Domenico G, Carla Russo, Paolo F, et al. Polymorphisms in the Factor VⅡ gene and the risk of myocardial infarction in patients with coronary artery disease[J]. N Engl J Med, 2000, 343:774-780. doi: 10.1056/NEJM200009143431104 |
|
[13]
|
lacoviello L, Di Castelnuovo A, de Knjf P, et al. Polymorphisms in the coagulation factor VⅡ gene and the risk of myocardial infarction[J]. N Engl J Med, 1998, 338:79-85. doi: 10.1056/NEJM199801083380202 |
|
[14]
|
Rosendaal FR, Siscovick DS, Schwartz SM, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women [J]. Blood, 1997, 89:2817-2821. doi: 10.1182/blood.V89.8.2817 |
|
[15]
|
Salomaa V, Matei C, Aleksic N, et al. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study[J]. Lancet, 1999, 353:1729-1734. doi: 10.1016/S0140-6736(98)09057-6 |
|
[16]
|
Norland L, Holm J, Zoller B, et al. A common thrombomodulin amino acid dimorphism is associated with myocardial infarction[J]. Thromb Haemost, 1997, 77:248-251. doi: 10.1055/s-0038-1655947 |
|
[17]
|
Thompson SG, Kienast J, Pyke SDN, et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris[J]. N Engl J Med, 1995, 332:635-641. doi: 10.1056/NEJM199503093321003 |
|
[18]
|
Ludwig M, Wihn KD, Scheuning WD, et al. Alleleie dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion event [J]. Hum Genet, 1992, 88:388-392. doi: 10.1007/BF00215671 |
|
[19]
|
Ladenvall P, Johansson L, Jansson JH, et al. Tissue-type plasminogen activator-7, 35 1C/T enhancer polymorphism is associated with a first myocardial infarction[J]. Thromb Haemost, 2002, 87: 105-109. doi: 10.1055/s-0037-1612951 |
|
[20]
|
Sobel BE, Woodcock-Mitchell J, Schneider DJ, et al. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with non-diabetic patients: a potential factor predisposing to thrombosis and its persistence[J]. Circulation, 1998, 97: 2213-2221. doi: 10.1161/01.CIR.97.22.2213 |
|
[21]
|
Margaglione M, Cappucci G, ColaizzoD, et al. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease[J]. Arterioscler Thromb Vase Biol, 1998, 18:152-156. doi: 10.1161/01.ATV.18.2.152 |
|
[22]
|
Weis EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis[J]. N Engl J Med, 1996, 334:1090-1094. doi: 10.1056/NEJM199604253341703 |
|
[23]
|
Herrmann SM, Poirier 0, Marques-Vidal P, et al. The Leu 33/Pro polymorphism (PIA1/PIA2) of the glycoprotein Ila (GPⅡa) receptor is not related to myocardial infarction in the ECTIM Study[J]. Thomb Haemost, 1997, 77:1179-1181. doi: 10.1055/s-0038-1656134 |
|
[24]
|
Gonzalez-Conejero R, Lozano ML, Rivera J, et al. Polymorphisms of platelet membrane glycoprotein lba associated with arterial thrombotie disease[J]. Blood, 1998, 92: 2771-2776. doi: 10.1182/blood.V92.8.2771 |
|
[25]
|
The W llcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls[J]. Nature, 2007, 447: 661-677. |
|
[26]
|
Hardy J, Singleton A, Genomewide association studies and human disease[J]. N Engl J Med, 2009, 360: 1759-1768. |
作者投稿
专家审稿
编辑办公
邮件订阅
RSS
点击查看大图
下载:
